Wedbush Maintains Outperform on Imax, Lowers Price Target to $22

Wedbush maintains Imax (NYSE:IMAX) with a Outperform and lowers the price target from $28 to $22.

Benzinga · 02/03/2020 13:26

Wedbush maintains Imax (NYSE:IMAX) with a Outperform and lowers the price target from $28 to $22.